Cue Biopharma
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.80-0.76-2.310.81
Price/Sales ratio
1.751.320.330.13
Earnings per Share (EPS)
$-1.00$-1.05$-0.35$0.99

Historical Multiples (2015 – 2023)

2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-124.46-31.34-10.33-2.42-9.53-8.01-8.01-1.92-2.38-1.37-5.98
Price/Sales ratio
N/AN/AN/A82.81101.18113.7723.6881.5922.0048.81107.48
Price/Book Value ratio
34.5915.813.892.786.414.545.401.543.251.685.47
Price/Cash Flow ratio
-144.82-40.22-19.68-3.58-11.36-11.04-9.11-2.43-3.02-1.67-7.47
Price/Free Cash Flow ratio
-99.52-37.01-17.91-3.34-11.34-10.84-8.90-2.42-3.02-1.66-7.34
Price/Earnings Growth ratio
N/A-0.10-0.05-0.030.661.330.83-0.380.090.390.99
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/A-2398.15%-694.89%-963.48%111.89%-45.03%-593.93%N/A-1546.52%
Operating Profit Margin
N/AN/AN/A-3386.70%-1063.30%-1427.96%-292.55%-4274.30%-949.89%-3558.02%-1245.63%
Pretax Profit Margin
N/AN/AN/A-3339.32%-1049.33%-1413.25%-292.25%-4257.08%-924.09%-3543.16%-1231.29%
Net Profit Margin
N/AN/AN/A-3411.53%-1061.24%-1419.79%-295.56%-4239.86%-924.09%-3543.16%-1240.52%
Effective Tax Rate
N/AN/AN/A-2.16%-1.13%-0.46%-1.13%0.40%N/AN/A-1.64%
Return on Assets
-26.36%-47.04%-34.70%-85.92%-51.25%-44.99%-52.95%-57.83%-82.45%-88.15%-48.12%
Return On Equity
-27.79%-50.46%-37.71%-114.74%-67.23%-56.75%-67.42%-80.38%-136.80%-133.63%-61.99%
Return on Capital Employed
-27.66%-50.34%-37.71%-98.85%-61.33%-54.12%-61.90%-66.75%-117.32%-101.34%-57.72%
Liquidity Ratios
Current Ratio
N/AN/A12.166.535.235.36N/AN/AN/A6.685.88
Quick Ratio
19.0114.1712.126.533.935.365.356.683.016.615.23
Cash ratio
18.7113.9811.883.343.804.585.034.462.844.463.57
Days of Sales Outstanding
N/AN/AN/AN/A79.68164.0276.7616.78112.899.20121.85
Days of Inventory outstanding
N/AN/A196.17N/A200.77N/A-0.000.00N/AN/A100.38
Operating Cycle
N/AN/AN/AN/A280.45164.0276.7616.78112.89N/A222.23
Days of Payables Outstanding
1.13K946.091.15K26.0211.7222.52-531.84551.9233.54N/A17.12
Cash Conversion Cycle
N/AN/AN/A-26.02268.73141.49608.60-535.1479.34N/A205.11
Debt Ratios
Debt Ratio
N/AN/AN/AN/A0.060.040.05153.960.130.280.17
Debt Equity Ratio
N/AN/AN/AN/A0.080.060.07213.970.220.380.23
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.990.100.17N/A
Total Debt to Capitalization
N/AN/AN/AN/A0.070.050.070.990.180.220.15
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-85.53N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/A-6.92-6.80-7.87-0.00-4.89-3.42-5.17
Company Equity Multiplier
1.051.071.081.331.311.261.271.381.651.381.32
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/A-23.11-8.90-10.30-2.59-33.57-7.27-29.15-9.60
Free Cash Flow / Operating Cash Flow Ratio
1.451.081.091.071.001.011.021.0011.001.00
Cash Flow Coverage Ratio
N/AN/AN/AN/A-6.92-6.80-7.87-0.00-4.89-3.42-5.17
Short Term Coverage Ratio
N/AN/AN/AN/A-6.92-6.80-7.87-21.29-10.08-12.58-6.86
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A